Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection

Silva, Elisabeth Martins da; Guillermo, Landi Veivi Costilla; Gomes, Flávia Lima Ribeiro; Meis, Juliana De; Nunes, Marise Pinheiro; Senra, Juliana Fraga Vasconcelos; Soares, Milena Botelho Pereira; Reis, George Alexandre dos; Lopes, Marcela de Freitas.
Artículo en Inglés | ARCA | ID: arc-10113

Documentos relacionados

  1. Microalgae extracts modulates the immune response in Trypanosoma cruzi-infected human cells.
  2. Complementary Paths to Chagas Disease Elimination: The Impact of Combining Vector Control With Etiological Treatment.
  3. Trypanosoma cruzi killing and immune response boosting by novel phenoxyhydrazine-thiazole against Chagas disease.
  4. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
  5. In Vitro and in Vivo Study of a Photostable Quinone Compound with Enhanced Therapeutic Efficacy against Chagas Disease.
  6. Listen to what the animals say: a systematic review and meta-analysis of sterol 14-demethylase inhibitor efficacy for in vivo models of Trypanosoma cruzi infection.
  7. Chagas disease in immunocompromised patients.
  8. Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models.
  9. Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole.
  10. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.